Skip to main content
. 2015 Jul 14;10:1313–1320. doi: 10.2147/COPD.S78180

Table 1.

Anthropometric and functional characteristics of 139 patients grouped according to GOLD spirometric grades

All GOLD grade
ANOVA P-value
2 3 4
N 139 46 56 37
Sex, M/F 134/5 46/0 53/3 35/2
Age (yr) 63±8 63±8 63±7 60±7 NS
BMI (m/kg2) 25±4 24±4 26±3 24±4 NS
FVC (% pred) 72±18 82±14 71±17* 60±17*, <0.001
FEV1 (L) 1.3±0.6 1.9±0.5 1.2±0.2* 0.7±0.2*, <0.001
FEV1 (% pred) 41±16 59±7 39±6* 20±4*, <0.001
FEV1/FVC (%) 40±15 52±8 41±14* 25±8*, <0.001
TLC (% pred) 116±21 113±17 112±22 124±22 0.004
RV (% pred) 200±75 156±44 191±69* 266±68*, <0.001
IC (% pred) 62±18 76±16 63±16* 47±12*, <0.001
RV/TLC (%) 61±11 52±8 59±9* 71±8*, <0.001
IC/TLC ratio 0.26±0.07 0.32±0.06 0.27±0.07* 0.18±0.05*, <0.001
DLco (% pred) 57±25 72±23 59±21* 36±15*, <0.001
PaO2 (mmHg) 69±12 77±10 68±11* 62±11*, <0.001
PaCO2 (mmHg) 40±6 37±4 41±6* 45±7*, <0.001
AaPO2 (mmHg) 32±10 30±11 32±9 34±10 NS

Notes: Data are presented as means ± standard deviation. Significant differences within each variable are indicated as:

*

different from GOLD grade 2;

different from GOLD grade 3.

Abbreviations: AaPO2, alveolar–arterial oxygen partial pressure difference; ANOVA, analysis of variance; BMI, body mass index; DLco, diffusing capacity for carbon dioxide; FEV1, post-bronchodilator forced expiratory volume in 1 second; FEV1/FVC, post-bronchodilator forced expiratory volume in 1 second/post-bronchodilator forced vital capacity; FVC, post-bronchodilator forced vital capacity; GOLD, Global Initiative for Chronic Obstructive Pulmonary Disease; IC, inspiratory capacity; IC/TLC, inspiratory capacity/total lung capacity ratio; M/F, male/female; NS, not significant; PaCO2, partial pressure of arterial carbon dioxide; PaO2, partial pressure of arterial oxygen; pred, predicted; RV, residual volume; RV/TLC, residual volume/total lung capacity ratio; TLC, total lung capacity.